PLAT and androgen insensitivity syndrome: Compared with 0.90 mg/kg for AIS, we first found that 0.65 mg/kg may be an optimal dose of r-tPA for mild to moderate stroke, which exhibited a higher proportion of excellent functional outcome and similar safety profile.